{"id":"W2991954549","doi":"10.2147/jaa.s227170","title":"<p>Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma</p>","year":2019,"lang":"en","type":"article","venue":"Journal of Asthma and Allergy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital","funders":"Pearl Therapeutics; Genentech; Sunovion; AstraZeneca; Chiesi Farmaceutici; CSL Behring; Mylan; GlaxoSmithKline; Biogen; Sanofi; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; American Thoracic Society","keywords":"Benralizumab; Medicine; Exacerbation; Asthma; Eosinophil; Internal medicine; Mepolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003465344,0.0002424554,0.001029382,0.0007830957,0.00004407583,0.00002582201,0.0001180531,0.0001332468,0.0008282863],"category_scores_gemma":[0.00009841085,0.0001735427,0.0002916186,0.0007531209,0.0001164808,0.0001728579,0.00006266436,0.0002845031,0.000006619843],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005602855,"about_ca_system_score_gemma":0.0002121505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001825359,"about_ca_topic_score_gemma":0.0001151481,"domain_scores_codex":[0.998066,0.0001271382,0.0008490546,0.0002527109,0.0004401895,0.0002648717],"domain_scores_gemma":[0.9985729,0.0001239368,0.0004702674,0.0002266863,0.0002766861,0.0003295239],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.04108518,0.005677153,0.3505699,0.001012854,0.02043927,0.003041167,0.005307255,0.01220474,0.1567768,0.009430951,0.008236559,0.3862181],"study_design_scores_gemma":[0.01147494,0.002208677,0.8537706,0.0005762287,0.0004201179,0.0003122606,0.0009105359,0.00125378,0.0002602245,0.00002919336,0.1284865,0.0002968885],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940298,0.003033207,0.00003987182,0.0003064947,0.0001045841,0.0001428483,0.00002741326,0.000008089009,0.002307694],"genre_scores_gemma":[0.9976521,0.0009730487,0.0003249243,0.0001466025,0.0001104929,8.547933e-7,0.00002140635,0.00002174499,0.0007488224],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5032007,"threshold_uncertainty_score":0.9069154,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006554322464625234,"score_gpt":0.2462140875855967,"score_spread":0.2396597651209715,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}